IRIS Accounts Production v26.2.0.496 SC791190 director 1.4.25 31.3.26 31.3.26 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC7911902025-03-31SC7911902026-03-31SC7911902025-04-012026-03-31SC7911902024-03-31SC7911902024-04-012025-03-31SC7911902025-03-31SC791190ns15:Scotland2025-04-012026-03-31SC791190ns14:PoundSterling2025-04-012026-03-31SC791190ns10:Director12025-04-012026-03-31SC791190ns10:PrivateLimitedCompanyLtd2025-04-012026-03-31SC791190ns10:SmallEntities2025-04-012026-03-31SC791190ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-31SC791190ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-31SC791190ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-31SC791190ns10:FullAccounts2025-04-012026-03-31SC791190ns10:OrdinaryShareClass12025-04-012026-03-31SC791190ns10:RegisteredOffice2025-04-012026-03-31SC791190ns5:CurrentFinancialInstruments2026-03-31SC791190ns5:CurrentFinancialInstruments2025-03-31SC791190ns5:ShareCapital2026-03-31SC791190ns5:ShareCapital2025-03-31SC791190ns5:RetainedEarningsAccumulatedLosses2026-03-31SC791190ns5:RetainedEarningsAccumulatedLosses2025-03-31SC791190ns5:ComputerEquipment2025-04-012026-03-31SC791190ns5:ComputerEquipment2025-03-31SC791190ns5:ComputerEquipment2026-03-31SC791190ns5:ComputerEquipment2025-03-31SC791190ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-31SC791190ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-31SC791190ns5:DeferredTaxation2025-03-31SC791190ns5:DeferredTaxation2025-04-012026-03-31SC791190ns5:DeferredTaxation2026-03-31SC791190ns10:OrdinaryShareClass12026-03-31
REGISTERED NUMBER: SC791190 (Scotland)















Unaudited Financial Statements for the Year Ended 31 March 2026

for

Oracle Radiology Ltd

Oracle Radiology Ltd (Registered number: SC791190)






Contents of the Financial Statements
for the Year Ended 31 March 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Oracle Radiology Ltd

Company Information
for the Year Ended 31 March 2026







DIRECTOR: Dr WS Pang





REGISTERED OFFICE: 25 Sandyford Place
Glasgow
G3 7NG





REGISTERED NUMBER: SC791190 (Scotland)





ACCOUNTANTS: Stevenson & Kyles
Chartered Accountants
25 Sandyford Place
Glasgow
G3 7NG

Oracle Radiology Ltd (Registered number: SC791190)

Balance Sheet
31 March 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,952 2,260

CURRENT ASSETS
Debtors 5 3,688 2,344
Cash at bank 1,838 1,085
5,526 3,429
CREDITORS
Amounts falling due within one year 6 6,773 4,064
NET CURRENT LIABILITIES (1,247 ) (635 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,705

1,625

PROVISIONS FOR LIABILITIES 7 561 430
NET ASSETS 1,144 1,195

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 1,044 1,095
SHAREHOLDERS' FUNDS 1,144 1,195

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Oracle Radiology Ltd (Registered number: SC791190)

Balance Sheet - continued
31 March 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 1 September 2026 and were signed by:





Dr WS Pang - Director


Oracle Radiology Ltd (Registered number: SC791190)

Notes to the Financial Statements
for the Year Ended 31 March 2026

1. STATUTORY INFORMATION

Oracle Radiology Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% on cost

Financial instruments
Basic financial instruments, including debtors and creditors with no stated interest rate and receivable or payable within one year, are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Oracle Radiology Ltd (Registered number: SC791190)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

2. ACCOUNTING POLICIES - continued

Grant income
Where applicable, grants from the government are recognised at their fair value where there is a reasonable assurance that the grant will be received and that the company will comply with all attached conditions. Where the grant income relates to a particular expense item, the grant income is recognised in the profit and loss account over the same period as the expense it is intended to compensate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2025 - 1 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 April 2025 3,392
Additions 2,049
At 31 March 2026 5,441
DEPRECIATION
At 1 April 2025 1,132
Charge for year 1,357
At 31 March 2026 2,489
NET BOOK VALUE
At 31 March 2026 2,952
At 31 March 2025 2,260

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 2,544 1,200
Other debtors 1,144 1,144
3,688 2,344

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Taxation and social security - 180
Other creditors 6,773 3,884
6,773 4,064

Oracle Radiology Ltd (Registered number: SC791190)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

7. PROVISIONS FOR LIABILITIES
2026 2025
£    £   
Deferred tax 561 430

Deferred
tax
£   
Balance at 1 April 2025 430
Provided during year 131
Balance at 31 March 2026 561

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2026 2025
value: £    £   
100 Ordinary £1 100 100

9. ULTIMATE CONTROLLING PARTY

The controlling party is Dr WS Pang.

The ultimate controlling party is Dr WS Pang.